Detalhe da pesquisa
1.
Performance of common genetic variants in risk prediction for colorectal cancer in Chinese: A two-stage and multicenter study.
Genomics
; 113(3): 867-873, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545268
2.
Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
J Pineal Res
; 60(1): 27-38, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26445000
3.
SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility.
Gene
; 640: 43-50, 2018 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28962925
4.
Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation.
Theranostics
; 8(5): 1312-1326, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29507622
5.
Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer.
Cell Death Dis
; 8(8): e3011, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28837144
6.
Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway.
Cell Death Dis
; 7(10): e2432, 2016 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27787516
7.
Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Cancer Lett
; 380(1): 87-97, 2016 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27322737
8.
Correction to: Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.
J Exp Clin Cancer Res
; 40(1): 208, 2021 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34167550
9.
Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.
J Exp Clin Cancer Res
; 35(1): 142, 2016 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27620004
10.
microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
Oncotarget
; 6(13): 10868-79, 2015 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869101
11.
Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].
Cancer Lett
; 469: 526, 2020 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623877